Trexquant Investment LP Gilead Sciences, Inc. Transaction History

Trexquant Investment LP

$6.33 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $548,117 - $598,006	-7,413 Reduced 26.94%	20,103 $1.51 Million
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $222,101 - $253,337	2,922 Added 11.88%	27,516 $2.12 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $352,301 - $401,380	-4,557 Reduced 15.63%	24,594 $2.04 Million
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $87,559 - $125,705	1,405 Added 5.06%	29,151 $2.5 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $1.34 Million - $1.53 Million	22,523 Added 431.23%	27,746 $1.71 Million
Q2 2022 Aug 11, 2022	SELL	$57.72 - $65.01 $9.07 Million - $10.2 Million	-157,204 Reduced 96.78%	5,223 $323,000
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $8.83 Million - $11.1 Million	152,397 Added 1519.41%	162,427 $9.66 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $650,746 - $738,609	10,030 New	10,030 $728,000
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $5.76 Million - $6.22 Million	-85,150 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$63.47 - $69.35 $5.09 Million - $5.57 Million	80,257 Added 1640.24%	85,150 $5.86 Million
Q1 2021 May 13, 2021	SELL	$60.0 - $68.46 $3.65 Million - $4.17 Million	-60,912 Reduced 92.56%	4,893 $316,000
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $1.16 Million - $1.32 Million	-20,489 Reduced 23.74%	65,805 $3.83 Million
Q3 2020 Nov 06, 2020	BUY	$62.1 - $78.08 $2.52 Million - $3.17 Million	40,626 Added 88.96%	86,294 $5.45 Million
Q2 2020 Aug 07, 2020	SELL	$72.34 - $84.0 $1.13 Million - $1.31 Million	-15,582 Reduced 25.44%	45,668 $3.51 Million
Q1 2020 May 08, 2020	SELL	$62.63 - $80.22 $2.52 Million - $3.22 Million	-40,172 Reduced 39.61%	61,250 $4.58 Million
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $1.83 Million - $2.01 Million	29,625 Added 41.26%	101,422 $6.59 Million
Q3 2019 Nov 08, 2019	BUY	$62.51 - $69.0 $1.65 Million - $1.82 Million	26,350 Added 57.98%	71,797 $4.55 Million
Q2 2019 Aug 09, 2019	SELL	$61.87 - $69.38 $2.16 Million - $2.42 Million	-34,849 Reduced 43.4%	45,447 $3.07 Million
Q1 2019 May 13, 2019	SELL	$62.53 - $70.05 $1.12 Million - $1.25 Million	-17,903 Reduced 18.23%	80,296 $5.22 Million
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $2.07 Million - $2.7 Million	34,141 Added 53.3%	98,199 $6.14 Million
Q3 2018 Nov 09, 2018	BUY	$71.28 - $78.92 $4.57 Million - $5.06 Million	64,058 New	64,058 $4.95 Million
Q4 2017 Feb 09, 2018	SELL	$71.15 - $83.52 $854,511 - $1 Million	-12,010 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$72.11 - $85.47 $866,041 - $1.03 Million	12,010	12,010 $973,000

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account